Coherus BioSciences, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.520
+0.040 (2.70%)
At close: Dec 20, 2024, 4:00 PM
1.510
-0.010 (-0.66%)
After-hours: Dec 20, 2024, 6:36 PM EST
Coherus BioSciences Market Cap
Coherus BioSciences has a market cap or net worth of $175.12 million as of December 20, 2024. Its market cap has decreased by -31.62% in one year.
Market Cap
175.12M
Enterprise Value
347.31M
1-Year Change
-31.62%
Ranking
Category
Stock Price
$1.52
Market Cap Chart
Since November 6, 2014, Coherus BioSciences's market cap has decreased from $404.20M to $175.12M, a decrease of -56.67%. That is a compound annual growth rate of -7.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 175.10M | -52.78% |
| Dec 29, 2023 | 370.80M | -39.81% |
| Dec 30, 2022 | 616.00M | -49.73% |
| Dec 31, 2021 | 1.23B | -2.13% |
| Dec 31, 2020 | 1.25B | -0.83% |
| Dec 31, 2019 | 1.26B | 105.12% |
| Dec 31, 2018 | 615.60M | 20.73% |
| Dec 29, 2017 | 509.90M | -58.50% |
| Dec 30, 2016 | 1.23B | 37.60% |
| Dec 31, 2015 | 893.00M | 64.52% |
| Dec 31, 2014 | 542.80M | 34.29% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sight Sciences | 181.19M |
| Genfit | 179.71M |
| MediWound | 177.93M |
| InfuSystem Holdings | 176.70M |
| Molecular Partners AG | 175.65M |
| Tevogen Bio Holdings | 174.35M |
| BrainsWay | 173.14M |
| Kyverna Therapeutics | 172.69M |